203 related articles for article (PubMed ID: 31648478)
1. [Expression of Tim-3 on natural killer cells in patients with acute myeloid leukemia and its clinical significance].
Ma JF; Li CX; Wu DP; Sun ZL; Yan CL
Zhonghua Xue Ye Xue Za Zhi; 2019 Sep; 40(9):755-758. PubMed ID: 31648478
[No Abstract] [Full Text] [Related]
2. Tim-3 is highly expressed in T cells in acute myeloid leukemia and associated with clinicopathological prognostic stratification.
Li C; Chen X; Yu X; Zhu Y; Ma C; Xia R; Ma J; Gu C; Ye L; Wu D
Int J Clin Exp Pathol; 2014; 7(10):6880-8. PubMed ID: 25400771
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Costimulatory Molecule Tim3 on NK Cells and Its Subsets in Patients with Acute Myeloid Leukemia].
Wu WH; Shao JW; Jiang YL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1899-1903. PubMed ID: 33283717
[TBL] [Abstract][Full Text] [Related]
4. Tim-3 expression by peripheral natural killer cells and natural killer T cells increases in patients with lung cancer--reduction after surgical resection.
Xu LY; Chen DD; He JY; Lu CC; Liu XG; Le HB; Wang CY; Zhang YK
Asian Pac J Cancer Prev; 2014; 15(22):9945-8. PubMed ID: 25520133
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of regulatory T cells, CD200 and TIM3 expression in cytogenetically normal acute myeloid leukemia.
Zahran AM; Mohammed Saleh MF; Sayed MM; Rayan A; Ali AM; Hetta HF
Cancer Biomark; 2018; 22(3):587-595. PubMed ID: 29843224
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia.
Wang J; Yang L; Dao FT; Wang YZ; Chang Y; Xu N; Chen WM; Jiang Q; Jiang H; Liu YR; Qin YZ
Leuk Lymphoma; 2022 Jan; 63(1):152-161. PubMed ID: 34405769
[TBL] [Abstract][Full Text] [Related]
7. [Expression and Significance of PD-1, TIM-3 and VISTA on T Cell of Acute Myeloid Leukemia Patients].
Ge MJ; Xu KL; Xu T; Tang YN; Li ZY; Yan ZL; Sun HY; Cheng H; Zhu F; Sang W; Huang YH; Qiu TT; Li DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):748-752. PubMed ID: 32552931
[TBL] [Abstract][Full Text] [Related]
8. [The Expression and Function of NK Cells in Patients with Acute Myeloid Leukemia].
Liu L; Chen X; Jin HM; Zhao SS; Zhu Y; Qian SX; Wu YJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Feb; 30(1):49-55. PubMed ID: 35123603
[TBL] [Abstract][Full Text] [Related]
9. Dysregulated Expression of Tim-3 and NKp30 Receptors on NK Cells of Patients with Chronic Lymphocytic Leukemia.
Hadadi L; Hafezi M; Amirzargar AA; Sharifian RA; Abediankenari S; Asgarian-Omran H
Oncol Res Treat; 2019; 42(4):202-208. PubMed ID: 30870839
[TBL] [Abstract][Full Text] [Related]
10. Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma.
Xu L; Huang Y; Tan L; Yu W; Chen D; Lu C; He J; Wu G; Liu X; Zhang Y
Int Immunopharmacol; 2015 Dec; 29(2):635-641. PubMed ID: 26428847
[TBL] [Abstract][Full Text] [Related]
11. [Expression and Clinical Significance of Leukemia Stem Cell Antigen in Acute Myeloid Leukemia].
Yao DD; Han BQ; Han YF; Zhang YQ; Jin YL; Dai HB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Dec; 26(6):1583-1588. PubMed ID: 30501688
[TBL] [Abstract][Full Text] [Related]
12. Increased TOX expression concurrent with PD-1, Tim-3, and CD244 expression in T cells from patients with acute myeloid leukemia.
Huang S; Liang C; Zhao Y; Deng T; Tan J; Zha X; Li Y; Chen S
Cytometry B Clin Cytom; 2022 Mar; 102(2):143-152. PubMed ID: 34913594
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and clinical correlation of TIM-3 and PD-1/PD-L1 expressions in leukemic cells and tumor microenvironment in newly diagnosed acute myeloid leukemia.
Chajuwan T; Kansuwan P; Kobbuaklee S; Chanswangphuwana C
Leuk Lymphoma; 2022 Feb; 63(2):450-456. PubMed ID: 34585994
[TBL] [Abstract][Full Text] [Related]
14. Rosuvastatin Intervention Decreased the Frequencies of the TIM-3+ Population of NK Cells and NKT Cells among Patients with Chronic Hepatitis B.
Norouzi A; Taziki S; Najafipasandi A; Mohammadi S; Roshandel G
Iran J Immunol; 2022 Sep; 19(3):255-262. PubMed ID: 36190380
[TBL] [Abstract][Full Text] [Related]
15. TNF-α-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer.
Zheng Y; Li Y; Lian J; Yang H; Li F; Zhao S; Qi Y; Zhang Y; Huang L
J Transl Med; 2019 May; 17(1):165. PubMed ID: 31109341
[TBL] [Abstract][Full Text] [Related]
16. Decreased TIM-3 expression of peripheral blood natural killer cells in patients with severe aplastic anemia.
Zhang T; Yuan X; Liu C; Li Y; Liu H; Li L; Ding K; Wang T; Wang H; Shao Z; Fu R
Cell Immunol; 2017 Aug; 318():17-22. PubMed ID: 28637584
[TBL] [Abstract][Full Text] [Related]
17. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1.
Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA
Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934
[TBL] [Abstract][Full Text] [Related]
18. Tim-3 expression on peripheral monocytes and CD3+CD16/CD56+natural killer-like T cells in patients with chronic hepatitis B.
Rong YH; Wan ZH; Song H; Li YL; Zhu B; Zang H; Zhao Y; Liu HL; Zhang AM; Xiao L; Xin SJ; You SL
Tissue Antigens; 2014 Feb; 83(2):76-81. PubMed ID: 24397461
[TBL] [Abstract][Full Text] [Related]
19. Increasing Tim-3+CD244+, Tim-3+CD57+, and Tim-3+PD-1+ T cells in patients with acute myeloid leukemia.
Tan J; Huang S; Huang J; Yu Z; Chen Y; Lu Y; Li Y; Chen S
Asia Pac J Clin Oncol; 2020 Jun; 16(3):137-141. PubMed ID: 32030888
[TBL] [Abstract][Full Text] [Related]
20. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]